CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
24/4 CIMIC breaks above the 10-day average after forming a new trend low mid-week at $16.86.
10/5 Dec 21 $20 call options are now trading at $1.10.
ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.
10/5 Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Qube Holdings is under Algo Engine buy conditions, with price support at $2.90. Consider a stop-loss on a break below the support.
In 2021, container port freight volumes are up on average 10 to 20% per month compared to last year.
Since writing the above post, QUB has found steady buying interest above the $2.90 support and the momentum indicators continue to trend higher.
A number of institutions have upgraded their price targets into the $3.40 to $3.60 range.
8/5 Buy Qube Holdings and consider a stop loss below $2.90.
We recommend investors add the IAA, (Asia top 50 ETF), and IZZ, (China Large-Cap ETF) to their watch lists.
There is a high probability that we’re now looking at oversold levels on both of these ETF’s and value is beginning to emerge.
Also look at the ASIA ETF, which provides exposure to technology focused companies.
WPL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Northern Star Resources is under Algo Engine buy conditions. The expected rally from sub $10 is now underway.
4/5 We again highlight Northern Star as our preferred gold play.
7/5
WPL:ASX is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
IAG:ASX is a potential counter-trend recovery trade that’s now on our radar. We add this to the list which also includes CIM & A2M.
6/5 Since writing the above post IAG has continued to move higher. Short-term investors may stick with the position as long as the price activity remains above the 10-day average.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.